Local complement activation in Nasal polyposis

Laryngoscope

Volumn 119, Issue 9, 2009, Pages 1753-1758

  Van Zele, Thibaut ^a   Coppieters, Frauke ^a   Gevaert, Philippe ^a   Holtappels, Gabriele ^a   Van Cauwenberge, Paul ^a   Bachert, Claus ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

C3a; C5a; Chronic rhinosinusitis with polyps; Complement; Membrane attack complex; Nasal polyposis

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; COMPLEMENT; COMPLEMENT COMPONENT C3A [DEARGININE]; COMPLEMENT COMPONENT C5A [DEARGININE]; COMPLEMENT MEMBRANE ATTACK COMPLEX; EOSINOPHIL CATIONIC PROTEIN; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NOSE MUCOSA; NOSE POLYP; NOSE SECRETION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ALPHA-MACROGLOBULINS; COMPLEMENT ACTIVATION; COMPLEMENT C3A; COMPLEMENT C5A; EOSINOPHIL CATIONIC PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NASAL POLYPS; PEROXIDASE; SERUM ALBUMIN;

EID: 70349601441     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20484     Document Type: Article

References (27)

1. Gasque P. Complement: a unique innate immune sensor for danger signals. Mol Immunol 2004;41:1089-1098.
2. Carroll MC. The complement system in regulation of adaptive immunity. Nat Immunol 2004;5:981-986.
3. Daffern PJ, Pfeifer PH, Ember JA, Hugli TE. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 1995;181:2119-2127.
4. Van Zele T, Gevaert P, Watelet JB, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004;114:981-983. (Pubitemid 39330280)
5. Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P. Nasal polyposis: from cytokines to growth. Am J Rhinol 2000;14:279-290.
6. Mygind N, Dahl R, Bachert C. Nasal polyposis, eosinophil dominated inflammation, and allergy. Thorax 2000; 55(suppl 2):S79-S83.
7. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006;61:1280-1289.
8. Voegels RL, Santoro P, Butugan O, Formigoni LG. Nasal polyposis and allergy: is there a correlation? Am J Rhinol 2001;15:9-14. (Pubitemid 33694156)
9. Gevaert P, Holtappels G, Johansson SG, Cuvelier C, Cauwenberge P, Bachert C. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 2005; 60:71-79.
10. Gevaert P, Bachert C, Holtappels G, et al. Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis. Allergy 2003;58:371-379.
11. Fink PC, Romer M, Haeckel R, et al. Measurement of proteins with the Behring Nephelometer. A multicentre evaluation. J Clin Chem Clin Biochem 1989;27:261-276.
12. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001;107:607-614.
13. Bachert C, Gevaert P, Holtappels G, van Cauwenberge P. Mediators in nasal polyposis. Curr Allergy Asthma Rep 2002;2:481-487.
14. Vandermeer J, Sha Q, Lane AP, Schleimer RP. Innate immunity of the sinonasal cavity: expression of messenger RNA for complement cascade components and toll-like receptors. Arch Otolaryngol Head Neck Surg 2004;130: 1374-1380.
15. Jagels MA, Daffern PJ, Hugli TE. C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology 2000;46:209-222.
16. DiScipio RG, Daffern PJ, Jagels MA, Broide DH, Sriramarao P. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J Immunol 1999;162:1127-1136.
17. Krug N, Tschernig T, Erpenbeck VJ, Hohlfeld JM, Kohl J. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Respir Crit Care Med 2001;164(10 pt 1):1841-1843.
18. Andersson M, Michel L, Llull JB, Pipkorn U. Complement activation on the nasal mucosal surface-a feature of the immediate allergic reaction in the nose. Allergy 1994;49: 242-245.
19. Humbles AA, Lu B, Nilsson CA, et al. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 2000;406:998-1001.
20. Gerard NP. Complement in allergy and asthma. Curr Opin Immunol 2002;14:705-708.
21. Lukacs NW, Glovsky MM, Ward PA. Complement-dependent immune complex-induced bronchial inflammation and hyperreactivity. Am J Physiol Lung Cell Mol Physiol 2001;280:L512-L518.
22. Sarma VJ, Huber-Lang M, Ward PA. Complement in lung disease. Autoimmunity 2006;39:387-394.
23. Peng T, Hao L, Madri JA, et al. Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response. J Clin Invest 2005; 115:1590-1600.
24. Tos M, Sasaki Y, Ohnishi M, Larsen P, Drake-Lee AB. Fireside conference 2. Pathogenesis of nasal polyps. Rhinol Suppl 1992;14:181-185.
25. Wagner C, Braunger M, Beer M, Rother K, Hansch GM. Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex. Exp Nephrol 1994;2:51-56.
26. Rus H, Cudrici C, David S, Niculescu F. The complement system in central nervous system diseases. Autoimmunity 2006;39:395-402.
27. Brandt J, Pippin J, Schulze M, et al. Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int 1996;49:335-343.